汇添富恒生生物科技ETF(QDII)(513280)利润分配表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
收入 |
101,159,755.96 |
-15,927,280.10 |
-40,046,387.38 |
-13,382,659.29 |
利息合计 |
23,798.04 |
54,497.55 |
14,500.35 |
18,749.49 |
其中:存款利息收入 |
23,798.04 |
54,497.55 |
14,500.35 |
18,749.49 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
11,069,550.08 |
-10,860,332.95 |
-6,215,938.70 |
-1,425,909.32 |
其中:股票投资收益 |
9,908,130.87 |
-13,599,540.73 |
-7,669,718.76 |
-2,393,685.22 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
- |
- |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
1,161,419.21 |
2,739,207.78 |
1,453,780.06 |
967,775.90 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
88,807,533.55 |
-5,900,652.73 |
-33,656,576.84 |
-11,424,925.42 |
其他收入 |
614,431.79 |
1,503,713.81 |
686,489.61 |
672,319.10 |
费用 |
342,105.78 |
516,241.27 |
234,301.74 |
356,102.64 |
管理人报酬 |
183,331.22 |
260,760.77 |
111,104.49 |
139,998.46 |
基金托管费 |
61,110.47 |
86,920.23 |
37,034.83 |
46,666.14 |
销售服务费 |
- |
- |
- |
- |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
97,664.09 |
168,560.27 |
86,162.42 |
169,438.04 |
利润总额 |
100,817,650.18 |
-16,443,521.37 |
-40,280,689.12 |
-13,738,761.93 |